Boobalan Pachaiyappan
Stock Analyst at Roth MKM
(0)
# 4220
Out of 5,267 analysts
8
Total ratings
37.50%
Success rate
-7.82%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Verona Pharma | Initiates Coverage On: Buy | 68 | 69.48 | -2.13% | 1 | Jan 10, 2025 | |
Reviva Pharmaceutica... | Initiates Coverage On: Buy | 7 | 1.44 | 386.11% | 1 | Jan 10, 2025 | |
Cingulate | Initiates Coverage On: Buy | 12 | 4.08 | 194.12% | 1 | Jan 10, 2025 | |
Gain Therapeutics | Maintains: Buy | 7 7 | 2.12 | 230.19% | 2 | Dec 24, 2024 | |
CervoMed | Initiates Coverage On: Buy | 45 | 2.19 | 1954.79% | 1 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 29 | 11.9 | 143.7% | 1 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 10 | 1.52 | 557.89% | 1 | Dec 5, 2024 |